Correlation Between Inozyme Pharma and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Atea Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Atea Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Atea Pharmaceuticals
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Atea is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Atea Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Atea Pharmaceuticals. In addition to that, Inozyme Pharma is 1.45 times more volatile than Atea Pharmaceuticals. It trades about -0.67 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.05 per unit of volatility. If you would invest 342.00 in Atea Pharmaceuticals on August 29, 2024 and sell it today you would lose (12.00) from holding Atea Pharmaceuticals or give up 3.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| Atea Pharmaceuticals |
Inozyme Pharma and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Atea Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |